Diagnostic Effectiveness of Virtual Bronchoscopy
Bronchogenic Carcinoma, Chronic Granulomatous Disease, Job's Syndrome
About this trial
This is an interventional treatment trial for Bronchogenic Carcinoma focused on measuring Wegener's Granulomatosis, Computer Assisted Visualization, Lung Cavities, Endobronchial Lesions, Computed Tomography (CT), Bronchogenic Carcinoma
Eligibility Criteria
Patients with Wegener's granulomatosis who are scheduled for fiberoptic bronchoscopy. Patients with cavitary lung diseases who are enrolled in protocols studying patients with Wegener's granulomatosis, chronic granulomatosis disease, host immune defects, mycobacterial infections, and Job's syndrome. Patients with bronchogenic carcinoma, other thoracic malignancies, or metastatic disease to the thorax. Patients will be selected from Clinical Center inpatient and outpatient population based on a clinical suspicion of pulmonary, mediastinal or bronchial disease, and are to have medically indicated chest CT. Written informed consent will be obtained from all patients and studies will only be done with the permission of the patient's attending physician. Patients will be drawn from the following protocols: 92-I-0186 93-I-0119 94-I-0149 95-I-0091 90-I-0086 76-I-0023 92-I-0255 93-I-0172 95-I-0177 Subjects must not be pregnant and be able to hold their breath for required periods of time.
Sites / Locations
- Warren G. Magnuson Clinical Center (CC)